(Reuters) - The U.S. Food and Drug Administration said on Tuesday it issued warning letters to three companies that illegally marketed and distributed products containing the substance, kratom, which they claimed treat opioid addiction and withdrawal.
OUAGADOUGOU (Reuters) - The Marie Stopes Ladies who drive from village to village in the remote north of Burkina Faso offering free contraception, advice on family planning, sexual health and sometimes abortion, may have to stop work in June.
BENGALURU/KOCHI (Reuters) - A rare virus spread by fruit bats, which can cause flu-like symptoms and brain damage, has killed 10 people in southern India, health officials said on Tuesday, with at least nine more being treated.
MBANDAKA, Democratic Republic of Congo (Reuters) - Two more people have died from Ebola and seven new cases were confirmed in Democratic Republic of Congo, authorities said on Tuesday, but resistance to some public guidance about preventing the disease was evident in a provincial capital.
(Reuters Health) - The surge in U.S. kids taking medication for attention-deficit hyperactivity disorder (ADHD) is having an unintended side effect, a new study suggests: more children and teens are overdosing on these drugs.
(Reuters) - Nabriva Therapeutics Plc's antibiotic drug to treat a common form of pneumonia met the main goal of a key clinical trial, but concerns over its side effects sent the drug developer's shares down 13 percent on Monday.
MBANDAKA, Democratic Republic of Congo (Reuters) - Congo began administering an experimental Ebola vaccine to medical staff in the northwestern city of Mbandaka on Monday to tackle an outbreak of the virus believed to have killed 26 people since early April.
LONDON (Reuters) - Britain's prime minister challenged scientists on Monday to help diagnose cancer earlier and create zero-emission cars, trying to reboot an industrial strategy all but eclipsed by Brexit, while acknowledging Britain's reliance on foreign scientists.
(Reuters) - The U.S Food and Drug Administration said on Monday it had approved Dova Pharmaceuticals Inc's drug to treat low blood platelet count in chronic liver disease (CLD) patients, who are scheduled to undergo a medical procedure.
(Reuters) - Nabriva Therapeutics Plc's pneumonia drug for adults met the main goal of a late-stage study, the company said on Monday, putting it on track to file a marketing application with U.S. regulators later this year.
LONDON (Reuters) - The decision by U.S. regulators to finally approve AstraZeneca's much-delayed excess potassium drug Lokelma gives the group another new medicine launch, boosting its portfolio as it strives to offset declining sales of older products.
GENEVA (Reuters) - The spread of Ebola to a major city in Democratic Republic of Congo is worrying but the outlook is much more optimistic than when a major outbreak was reported in West Africa in 2014, the head of the World Health Organization said on Monday.
LONDON (Reuters) - Roche's new hemophilia drug Hemlibra dramatically reduced bleeding in a broad population of hemophilia patients, results from two clinical trials showed on Monday, setting it up to take a dominant market position.
LONDON (Reuters) - Prime Minister Theresa May will call on Britain's health service, charities and artificial intelligence sector to work together to better identify patients with the early stages of cancer and stop thousands dying each year.